Compounded vs branded GLP-1s: what you are actually buying

What compounding actually is

A compounding pharmacy prepares a medication to order rather than dispensing a manufactured, FDA-approved product. Compounding is a long-established and legitimate part of pharmacy practice — it exists for patients who need a different dose, form, or excipient than the commercial product provides.

The critical distinction: compounded preparations are not FDA-approved and are not evaluated by FDA for safety, efficacy or quality. That is not a marketing caveat, it is the regulatory status. The approval that sits behind Wegovy or Zepbound does not extend to a compounded version of the same molecule.

This does not mean compounded products are inherently unsafe, and many people use them without incident. It means the quality assurance chain is different, and you are relying on the compounding pharmacy's standards rather than on a manufacturer's approved process.

The price gap, from published prices

At Mochi, compounded semaglutide is published at $60 and branded Wegovy at $299. At Lemonaid, compounded semaglutide is $299/month while branded Ozempic is $1,199/month and Wegovy $1,599/month. Alloy publishes compounded semaglutide starting at $70.

Novo Nordisk's own NovoCare pharmacy publishes branded Wegovy self-pay from $149/month for tablets to $399/month for the highest injection dose — considerably below the retail figures some telehealth providers quote for the same branded products.

The practical lesson: before assuming compounded is your only affordable route, check the manufacturer's own self-pay pricing. The gap between compounded and branded is often smaller than the gap between one provider's branded price and another's.

What you give up

Insurance coverage. Every provider we verified that offers compounded medication states plainly that insurance does not cover it. Ivím says so directly. If you have commercial coverage that includes GLP-1s, compounded is likely the more expensive route after your benefit.

Regulatory recourse. With an approved product there is a defined manufacturer, an approved label, and an established adverse-event reporting pathway tied to that product.

Dosing consistency. Compounded preparations may come in different concentrations and presentations than the branded product. That is sometimes the point — microdosing options exist precisely because of this flexibility — but it means the dose ladder may not map onto the studied one.

Questions to ask a compounding provider

Which compounding pharmacy prepares my medication, and is it a 503A or 503B facility? Several providers we reviewed do not publish this at all.

What testing does the pharmacy perform on each batch, and can I see a certificate of analysis? Henry notes that California requires additional compound testing, which suggests testing requirements vary by state.

What exactly am I being prescribed — the same molecule, or a salt form or combination? This matters and providers do not always volunteer it.

If I need to move to a branded product later, can you prescribe it? Providers like Ivím and Mochi carry both; Alloy and Henry publish compounded only.

A reasonable way to think about it

If you have insurance that covers branded GLP-1s, use it. The compounded route is not saving you money in that situation, and you are taking on the quality-assurance question for no financial reason.

If you are self-paying, compare compounded pricing against manufacturer self-pay pricing rather than against retail. The manufacturer route may be closer than you expect, and it comes with an approved product.

If compounded is genuinely the only route you can afford, go in with your eyes open about the regulatory status, ask the questions above, and prefer providers that will tell you which pharmacy is preparing your medication.